EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-155-5p Elevated by Ochratoxin A Induces Intestinal Fibrosis and Epithelial-to-Mesenchymal Transition through TGF-β Regulated Signaling Pathway In Vitro and In Vivo

Kyu Hyun Rhee, Seon Ah Yang, Min Cheol Pyo, Jae-Min Lim, Kwang-Won Lee iD

Toxins · 2023

DOI: 10.3390/toxins15070473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2023. Verfasst von Kyu Hyun Rhee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, MicroRNAs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Korea University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ochratoxin A (OTA) is a mycotoxin that induces fibrosis and epithelial-to-mesenchymal transitions (EMT) in kidneys and livers. It enters our bodies through food consumption, where it is absorbed in the intestines. However, the impact of OTA on the intestines is yet to be studied. MicroRNA (miRNAs) are small non-coding single-stranded RNAs that block the transcription of specific mRNAs and are, therefore, involved in many biochemical processes. Our findings indicate that OTA can induce EMT and intestinal fibrosis both in vivo and in vitro. This study examines the impact of OTA on intestinal toxicity and the role of miRNAs in this process. Following OTA treatment, miR-155-5p was the most elevated miRNA by next-generation sequencing. Our research showed that OTA increased miR-155-5p levels through transforming growth factor β (TGF-β), leading to the development of intestinal fibrosis and EMT. Additionally, the study identified that the modulation of TGF-β and miR-155-5p by OTA is linked to the inhibition of CCAAT/enhancer-binding protein β (C/EBPβ) and Smad2/3 accumulation in the progression of intestinal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor betaMicroRNAsHumansSignal TransductionIntestinesFibrosisEpithelial-Mesenchymal TransitionOchratoxins

Stichwörter der Autor:innen

EMTTGF-βintestinal fibrosismiR-155-5pochratoxin A

Substanzen

Transforming Growth Factor betaMicroRNAsochratoxin AOchratoxinsMIRN155 microRNA, human

Autor:innen und Institutionen

  • Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.

ORCID-Profile: Kwang-Won Lee

Förderung

  • National Research Foundation of Korea (NRF)
  • Korea University

Zitieren

APA

Rhee, K. H., Yang, S. A., Pyo, M. C., Lim, J. M., & Lee, K. W. (2023). MiR-155-5p Elevated by Ochratoxin A Induces Intestinal Fibrosis and Epithelial-to-Mesenchymal Transition through TGF-β Regulated Signaling Pathway In Vitro and In Vivo. Toxins. https://doi.org/10.3390/toxins15070473

Vancouver

Rhee KH, Yang SA, Pyo MC, Lim JM, Lee KW. MiR-155-5p Elevated by Ochratoxin A Induces Intestinal Fibrosis and Epithelial-to-Mesenchymal Transition through TGF-β Regulated Signaling Pathway In Vitro and In Vivo. Toxins. 2023. doi:10.3390/toxins15070473

BibTeX
@article{Rhee2023,
  author = {Rhee, Kyu Hyun and Yang, Seon Ah and Pyo, Min Cheol and Lim, Jae-Min and Lee, Kwang-Won},
  title = {MiR-155-5p Elevated by Ochratoxin A Induces Intestinal Fibrosis and Epithelial-to-Mesenchymal Transition through TGF-β Regulated Signaling Pathway In Vitro and In Vivo},
  journal = {Toxins},
  year = {2023},
  doi = {10.3390/toxins15070473}
}
Kostenlos starten →